Comparison of Tiotropium Inhalation Capsules and Oxitropium Metered Dose Inhalator (MDI) in Patients With Chronic Obstructive Pulmonary Disease (COPD)

PHASE3CompletedINTERVENTIONAL
Enrollment

161

Participants

Timeline

Start Date

September 30, 2000

Primary Completion Date

May 31, 2002

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

Tiotropium powder inhalation capsules

Powder inhalation via the HandiHaler® once daily

DRUG

Tersigan®

2 puffs of oxitropium three times daily via MDI

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY